immunomodulation < immunomodulatory < immunopathological

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by immunomodulatory

Number of relevant bibliographic references: 14.

Ident.	Authors (with country if any)	Title
000177 (2021)	Kevin L. Winthrop [États-Unis] ; Amanda E. Brunton [États-Unis] ; Susan Beekmann [États-Unis] ; Philip Polgreen [États-Unis] ; John Baddley [États-Unis] ; Kenneth G. Saag [États-Unis] ; Cassandra Calabrese [États-Unis] ; Leonard Calabrese [États-Unis] ; Philip C. Robinson [Australie] ; Zachary S. Wallace [États-Unis] ; Jeffrey R. Curtis [États-Unis]	SARS CoV-2 infection among patients using immunomodulatory therapies.
000393 (2021)	Alessia Alunno [Oman] ; Aurélie Najm [Royaume-Uni] ; Xavier Mariette [France] ; Gabriele De Marco [Royaume-Uni] ; Jenny Emmel [Royaume-Uni] ; Laura Mason [Royaume-Uni] ; Dennis G. Mcgonagle [Royaume-Uni] ; Pedro M. Machado [Royaume-Uni]	Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider.
000498 (2021)	Rupesh Agrawal [Singapour, Royaume-Uni] ; Ilaria Testi [Royaume-Uni] ; Cecilia S. Lee [États-Unis] ; Edmund Tsui [États-Unis] ; Marian Blazes [États-Unis] ; Jennifer E. Thorne [États-Unis] ; Annabelle A. Okada [Japon] ; Justine R. Smith [Australie] ; Peter J. Mccluskey [Australie] ; John H. Kempen [États-Unis, Éthiopie] ; Christoph Tappeiner [Suisse] ; Manisha Agarwal [Inde] ; Bahram Bodaghi [France] ; Quan Dong Nguyen [États-Unis] ; Vishali Gupta [Inde] ; Marc D. De Smet [Belgique] ; Manfred Zierhut [Allemagne] ; Carlos Pavesio [Royaume-Uni]	Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic.
000B54 (2020)	Tyler C. Beck [États-Unis] ; Kyle R. Beck [États-Unis] ; Calvin B. Holloway [États-Unis] ; Richard A. Hemings [États-Unis] ; Thomas A. Dix [États-Unis] ; Russell A. Norris [États-Unis]	The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine.
000E71 (2020)	John G. Rizk [États-Unis] ; Kamyar Kalantar-Zadeh [États-Unis] ; Mandeep R. Mehra [États-Unis] ; Carl J. Lavie [États-Unis] ; Youssef Rizk [Liban] ; Donald N. Forthal [États-Unis]	Pharmaco-Immunomodulatory Therapy in COVID-19.
000F49 (2020)	Allan Giri [États-Unis] ; Ankita Das [Inde] ; Ajoy K. Sarkar [Inde] ; Ashok K. Giri [Inde]	Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19.
001105 (2020)	Mahdieh Razmi [Iran] ; Farideh Hashemi [Iran] ; Elmira Gheytanchi [Iran] ; Masoumeh Dehghan Manshadi [Iran] ; Roya Ghods [Iran] ; Zahra Madjd [Iran]	Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review.
001106 (2020)	Jaume Alijotas-Reig [Espagne] ; Enrique Esteve-Valverde [Espagne] ; Cristina Belizna [France] ; Albert Selva-O'Callaghan [Espagne] ; Josep Pardos-Gea [Espagne] ; Angela Quintana [Espagne] ; Arsene Mekinian [France] ; Ariadna Anunciacion-Llunell [Espagne] ; Francesc Mir Mur [Espagne]	Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review.
001107 (2020)	Laurel C. Chandler [Royaume-Uni] ; Imran H. Yusuf [Royaume-Uni] ; Michelle E. Mcclements [Royaume-Uni] ; Alun R. Barnard [Royaume-Uni] ; Robert E. Maclaren [Royaume-Uni] ; Kanmin Xue [Royaume-Uni]	Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy.
001108 (2020)	Daniel R. Burrage [Royaume-Uni] ; Soraya Koushesh [Royaume-Uni] ; Nidhi Sofat [Royaume-Uni]	Immunomodulatory Drugs in the Management of SARS-CoV-2.
001341 (2020)	Seidu A. Richard ; Sylvanus Kampo [Ghana] ; Maite Esquijarosa Hechavarria [Ghana] ; Marian Sackey ; Alexis D B. Buunaaim [Ghana] ; Eugene Dogkotenge Kuugbee [Ghana] ; Thomas Winsum Anabah [Ghana]	Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine.
001441 (2020)	Ming Zhao [République populaire de Chine]	Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies.
001787 (2020)	Muhammad Asif [Pakistan] ; Mohammad Saleem [Pakistan] ; Malik Saadullah [Pakistan] ; Hafiza Sidra Yaseen [Pakistan] ; Raghdaa Al Zarzour [Malaisie]	COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties.
001A15 (2020)	Nilesh Mahale [Inde] ; Prasad Rajhans [Inde] ; Purushotham Godavarthy [Inde] ; Vikram L. Narasimhan [Inde] ; Gauri Oak [Inde] ; Srinath Marreddy [Inde] ; Amruta Bedekar [Inde] ; Ujwal Dhundi [Inde] ; Harshwardhan S. Pawar [Inde] ; Prasad Akole [Inde] ; Balasaheb Pawar [Inde] ; Bhagyashri Bhurke [Inde] ; Shailaja Chavan [Inde] ; Parikshit Prayag [Inde] ; Bharat Purandare [Inde] ; Pradip Dalvi [Inde] ; Vishnu Telbhare [Inde] ; Prasanna Marudwar [Inde] ; Dnyaneshwar Diwane [Inde] ; Manasi Shahane [Inde] ; Amrita Prayag [Inde] ; Shradha Gugale [Inde] ; Shreyas Bhor [Inde] ; Sameer Jog [Inde]	A Retrospective Observational Study of Hypoxic COVID-19 Patients Treated with Immunomodulatory Drugs in a Tertiary Care Hospital.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "immunomodulatory" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "immunomodulatory" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    immunomodulatory
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021